Skip to main content
FinSpry Logo
FinSpry
GALT logo
GALT
(NASDAQ)
Galectin Therapeutics Inc.
$2.67-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Galectin Therapeutics (GALT) Stock Price & Financial Analysis

Galectin Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.55 - $2.72
52-Week High$7.13
52-Week Low$1.12
Open$2.66
Volume242.72K
Average Volume (3M)242.72K
Market Cap171.43M
Shares Outstanding64.20M
EV/EBITDA-9.38
50-Day MA$2.97
200-Day MA$3.95
52-Week Change112.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Galectin Therapeutics

What is the current stock price for GALT?

As of the latest trading session, GALT stock trades at $2.67. The 52-week range is $1.12–$7.13, with a day range of $2.55–$2.72.

What is the P/E ratio for GALT?

The P/E ratio (Price-to-Earnings) for GALT is shown in the Key Statistics section. This valuation metric helps compare Galectin Therapeutics Inc. to industry peers.

Does GALT pay dividends?

Galectin Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GALT?

Analyst ratings and recommendations for GALT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GALT?

Galectin Therapeutics's market capitalization is $171.4M, classifying it as a micro-cap company. Galectin Therapeutics operates in the Healthcare sector within the Biotechnology industry.